Results 111 to 120 of about 29,080 (157)

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma. [PDF]

J Clin Invest
Werr L, Boland J, Petersen J, Iglesias F, Höppner S, Bartenhagen C, Rosswog C, Hellmann AM, Kahlert Y, Hemstedt N, Ibruli N, Dammert MA, Decarolis B, Werner JM, Malchers F, Schramm K, Witt O, Beiske KH, Rognlien AGW, Gunnes MW, Langenberg KP, Molenaar J, Bernkopf M, Taschner-Mandl S, Hughes D, George SL, Chesler L, Schulte JH, Barone G, Capasso M, Surrey LF, Bagatell R, Masliah-Planchon J, Schleiermacher G, Grüll H, Westermann F, Schultheis AM, Büttner R, Henssen AG, Eggert A, Peifer M, Shukla NN, Simon T, Hero B, Reinhardt HC, Thomas RK, Fischer M.   +46 more
europepmc   +1 more source

A novel mutation in exon 18 of <i>FGFR1</i> causing hypoparathyroidism: A case report. [PDF]

J Int Med Res
Cao X, Zhu Y, Sun R, Sun H.
europepmc   +1 more source

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy. [PDF]

JCO Precis Oncol
Duan Y, Hashimoto T, Shibuki T, Taniguchi H, Sunakawa Y, Komatsu Y, Takahashi N, Sato Y, Yamaguchi K, Nishina T, Nakanoko T, Boku S, Satoh T, Yasui H, Esaki T, Imai M, Fujisawa T, Nakamura Y, Bando H, Yoshino T.   +19 more
europepmc   +1 more source

Conceptualization of fibroblast growth factor receptor 1 targeting nanomedicines. [PDF]

Explor Target Antitumor Ther
Ma Y, Guo M, Liu Y, Huang Z.
europepmc   +1 more source

Genetic variants in Ecuadorian families: unraveling the complexity of non-syndromic cleft lip and palate a case series. [PDF]

BMC Oral Health
Luna-Chonata D, Guaillas-Japon A, Almeida N, Romero VI, Arias-Almeida B, Palacios I.   +5 more
europepmc   +1 more source

A Multikinase Inhibitor AX-0085 Blocks FGFR1 Activation to Overcomes Osimertinib Resistance in Non-Small Cell Lung Cancer. [PDF]

Biomedicines
Rhie BH, Karapurkar JK, Kim HY, Woo SH, Gowda DAA, Kim DH, Choi MJ, Park YJ, Matam V, Hong Y, Hong SH, Ramakrishna S, Kim KS.   +12 more
europepmc   +1 more source

A Chemically Inducible Multimerization System for Tunable and Background-Free RTK Activation. [PDF]

Anal Chem
Zheng Y, Fei J, Chakrabarti A, Zhou R.
europepmc   +1 more source

Special Issue "Hormone Signaling in Human Health and Diseases". [PDF]

Int J Mol Sci
Muscella A.
europepmc   +1 more source

Discovery of novel FGFR1 inhibitors for oral squamous cell carcinoma using a multi-class QSAR model, virtual screening, and molecular dynamics simulations. [PDF]

BMC Cancer
Udeabor SE, Ishfaq M, Shah SJ, Khalid I, Baig F, Hamid MMM, Elfadeel ASA, Onwuka CI, Ali SAA, Mustafa MM.   +9 more
europepmc   +1 more source

FGFRL1 modulation of FGFR1 signaling

Reactome - a curated knowledgebase of biological pathways, 2016
openaire   +1 more source